Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Hims & Hers Health, Inc. HIMS

Healthcare  —  Drug Manufacturers Specialty & Generic
29.42 0.14 0.48% as of 25 Sep
Market cap
$6.9B
P/E
0.0×
Cash Flow Champion (3y) Revenue Champion (3y) Insider Buys (last 12m)
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Hims & Hers Health, Inc. (HIMS) Business Profile

Updated before January 2025

Company Overview

Hims & Hers Health, Inc. (HIMS) is a telehealth company that provides a modern approach to healthcare by offering direct-to-consumer access to medical products and services. Founded in 2017 by Andrew Dudum, HIMS was established with the mission to make healthcare more accessible, affordable, and convenient for everyone. The company is headquartered in San Francisco, California, and operates primarily in the United States. Andrew Dudum, who serves as the CEO, has been instrumental in driving the company’s vision of destigmatizing health issues and providing discreet, high-quality care. Other key members of the leadership team include Melissa Baird, the Chief Operating Officer, and Spencer Lee, the Chief Financial Officer.

HIMS went public in January 2021 through a merger with a special purpose acquisition company (SPAC), Oaktree Acquisition Corp. Since its inception, the company has grown rapidly, leveraging technology to disrupt traditional healthcare models and cater to the needs of a digitally savvy audience.

Core Business Segments

HIMS operates across several core business segments, offering a wide range of products and services tailored to address common health concerns. These segments include:

1. Men’s Health

  • Erectile Dysfunction (ED): HIMS provides prescription medications such as Sildenafil (generic Viagra) and Tadalafil (generic Cialis) to treat ED.
  • Hair Loss: Products include Finasteride and Minoxidil, which are FDA-approved treatments for male pattern baldness.
  • Skincare: Offerings include prescription and over-the-counter solutions for acne, anti-aging, and other skin concerns.

2. Women’s Health

  • Birth Control: HIMS offers a variety of oral contraceptives that can be prescribed online and delivered discreetly.
  • Skincare: Products include treatments for acne, melasma, and anti-aging.
  • Sexual Wellness: The company provides solutions for low libido and other sexual health concerns.

3. Mental Health

  • Therapy Services: HIMS connects users with licensed therapists for virtual counseling sessions.
  • Medications: The company offers prescription medications for anxiety, depression, and other mental health conditions.

4. Primary Care

  • HIMS provides access to general healthcare services, including consultations for common conditions like allergies, infections, and more.

5. Wellness Products

  • HIMS also offers a range of wellness products, including vitamins, supplements, and personal care items.

Business Model

HIMS operates on a direct-to-consumer (DTC) model, leveraging its online platform to provide telehealth consultations, prescriptions, and over-the-counter products. The company integrates products and services seamlessly by connecting users with licensed healthcare professionals who can diagnose conditions and prescribe treatments. These prescriptions are then fulfilled through HIMS’s network of partner pharmacies and delivered directly to customers’ homes.

Revenue is generated through:

  • Subscription Services: Many of HIMS’s products, such as ED medications and hair loss treatments, are offered on a subscription basis, ensuring recurring revenue.
  • One-Time Purchases: Customers can also buy certain products without committing to a subscription.
  • Consultation Fees: HIMS charges for telehealth consultations, which are often bundled with product purchases.

This model allows HIMS to maintain competitive pricing while offering convenience and privacy to its customers.

Strategic Direction

HIMS is focused on expanding its product offerings and geographic reach. Key strategic priorities include:

  • Service Growth: The company aims to broaden its telehealth services, particularly in mental health and primary care, to cater to a wider audience.
  • New Product Categories: HIMS is exploring opportunities in areas such as weight management, dermatology, and chronic condition management.
  • Sustainability Goals: The company is committed to reducing its environmental impact by adopting sustainable packaging and supply chain practices.
  • Global Expansion: While currently focused on the U.S. market, HIMS has plans to expand internationally, targeting regions with growing demand for telehealth services.

Competitive Landscape

HIMS operates in a highly competitive market, facing competition from both traditional healthcare providers and other telehealth companies. Key competitors include:

  • Telehealth Companies: Competitors like Teladoc Health and Ro (formerly Roman) offer similar telemedicine services and products.
  • Pharmaceutical Retailers: Companies like CVS Health and Walgreens pose competition through their in-store and online healthcare services.
  • Direct-to-Consumer Brands: Startups like Keeps and Nurx compete in specific niches such as hair loss and women’s health.

HIMS differentiates itself through its user-friendly platform, affordable pricing, and focus on destigmatizing health issues.

Risk Factors

HIMS faces several risks that could impact its business:

  • Market Dependence: The company relies heavily on a few key product categories, such as ED medications and hair loss treatments, for a significant portion of its revenue.
  • Regulatory Challenges: As a healthcare provider, HIMS must comply with stringent regulations, which could pose challenges as it expands into new markets.
  • Supply Chain Disruptions: Any disruptions in the supply chain, such as delays in manufacturing or shipping, could impact product availability.
  • Competition: The telehealth market is becoming increasingly crowded, which could pressure HIMS to lower prices or increase marketing spend.

Recent Developments

In recent years, HIMS has introduced several new initiatives and products:

  • Mental Health Expansion: The company has significantly expanded its mental health offerings, including therapy services and medications for anxiety and depression.
  • Partnerships: HIMS has partnered with major retailers like Target to make its products more accessible.
  • Technological Innovations: The company continues to enhance its platform with AI-driven tools to improve the customer experience.
  • COVID-19 Impact: The pandemic accelerated the adoption of telehealth services, providing a significant boost to HIMS’s business.

Investment Considerations

Strengths:

  • Strong Brand: HIMS has established itself as a trusted name in telehealth.
  • Recurring Revenue: The subscription-based model ensures a steady stream of income.
  • Growth Potential: The telehealth market is expected to grow significantly in the coming years, providing ample opportunities for HIMS.

Risks:

  • High Competition: The telehealth space is crowded, with many players vying for market share.
  • Regulatory Risks: Changes in healthcare regulations could impact the company’s operations.
  • Customer Retention: Maintaining customer loyalty in a competitive market is a challenge.

Conclusion

Hims & Hers Health, Inc. is a pioneer in the telehealth industry, offering a wide range of products and services that cater to modern healthcare needs. With a strong brand, innovative business model, and focus on accessibility, HIMS is well-positioned for growth. However, the company must navigate challenges such as competition and regulatory risks to maintain its momentum. As the telehealth market continues to expand, HIMS is poised to play a significant role in shaping the future of healthcare.